Find clinical trials for Multiple Sclerosis (MS) in Washington, DC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Sclerosis (MS) trials near Washington, DC, USA:
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis...
Phase 3
Washington D.C., District of Columbia, United States and 50 other locations
sclerosis (MS) and have recently been advised to start the medication ublituximab (Briumvi) or are currently on another medication ...
Baltimore, Maryland, United States
due to cancer or other illnesses such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson'...
Phase 2
Rockville, Maryland, United States and 21 other locations
Many patients with multiple sclerosis (MS) experience "relapses" of disease activity during which they have increased numb...
Baltimore, Maryland, United States
In this study, researchers will learn more about a study drug called BIIB091 in participants with MS who may be experiencing relapses. It is...
Phase 2
Lutherville, Maryland, United States and 78 other locations
The proposed study is a pilot study of ublituximab involving people with multiple sclerosis (MS) who are experiencing a "w...
Phase 4
Baltimore, Maryland, United States
of nasal foralumab in patients with non-active secondary progressive multiple sclerosis (SPMS).The primary objectives that this stu...
Phase 2
Baltimore, Maryland, United States and 6 other locations
Fatigue is a prevalent and disabling symptom in Multiple Sclerosis (MS), affecting up to 90% of patients. Current treatmen...
Phase 2
Baltimore, Maryland, United States
This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofat...
Phase 4
Lutherville, Maryland, United States and 42 other locations
This double-blind, double-dummy study will evaluate the safety and efficacy of ocrelizumab compared with fingolimod in children and adolescents with...
Phase 3
Washington D.C., District of Columbia, United States and 102 other locations
Clinical trials
Research sites
Resources
Legal